This side-by-side look makes it easier to weigh the pros and cons for your situation
Last reviewed: June 23, 2026 Last updated: June 23, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
The first GLP1 drug was approved in 2005, after researchers discovered that compounds derived from Gila monster saliva could stimulate insulin release
Despite their proven effectiveness, there is still a stigma around using medications for weight loss
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
These changes indicate a healthier liver, which is vital for processing nutrients and detoxification